NCT06943235View on ClinicalTrials.gov

Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC)

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

April 30, 2027

Study Completion Date

December 30, 2027

Conditions
Limited Stage Small Cell Lung Cancer
Interventions
DRUG

Probiotics

Subjects received probiotics before radiotherapy

RADIATION

concurrent Hyperfractionated Radiotherapy

Increase radiation dose on the basis of conventional radiotherapy

Trial Locations (1)

Unknown

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER